The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.
Inhaled antibody therapy shows promise for COVID-19 treatment
- Post author:admin
- Post published:February 12, 2025
- Post category:uncategorized